2024年4月17日 · If your doctor says your breast cancer is HER2-negative, it means your cancer isn’t making a lot of extra HER2. If your cancer were making extra HER2, it would be HER2-positive.

2023年3月14日 · HER2-negative breast cancer is the most common type, with subtypes such as hormone receptor positive or negative. These affect types of treatments chosen, as well as the survival rate. Learn...

2024年5月20日 · In the United States, 81% of new female breast cancer cases from 2017 through 2021 were HER2-negative, according to the National Cancer Institute (NCI). In 6% of cases, the HER2 status was...

2024年7月25日 · This article provides a general overview of HER2-negative breast cancers, which occur for reasons other than a faulty HER2 gene. It lists the treatment options for different types of...

2024年8月29日 · HER2-negative status means cancer cells have no or low amounts of HER2 proteins, making them less aggressive. Unlike HER2-positive breast cancer cells, however, HER2-negative cancer cells do not respond to some HER2-targeted therapies.

2024年6月27日 · HER2-negative and HER2-positive are types of breast cancer that share some things in common, but they have plenty of differences, too. Which kind you have can affect the treatment you get.

2024年7月31日 · HER2-negative breast cancer is characterized by the absence of the HER2 protein. Learn the symptoms, risk factors, diagnosis, prognosis, and treatment options.

2024年4月24日 · Most breast cancers are HER2-negative. There are many treatment options for this type of breast cancer. Your treatment will depend on factors such as hormone receptor status, cancer stage,...

2024年8月29日 · Breast cancer cells that test negative for hormone receptors and HER2 proteins are considered HR negative, HER2 negative. This type of cancer can sometimes be referred to using the term “triple negative” based on the negative test result for the two hormone receptors and HER2 proteins.

2024年6月2日 · HER2-negative breast cancer is a type of breast cancer that accounts for about 78% of all breast cancer cases. Its name describes the status of the human epidermal growth factor receptor 2, known as HER2, in the disease. Not all breast cancer cases are the same.